Anti-HSP65 and anti-HSP60 autoantibodies have been reported in post-operative AF, while anti-HSP70 autoantibodies are associated with AF recurrence post-ablation therapy [7–9]. The gene discussed is HSPD1; the disease is atrial fibrillation.